Moneycontrol PRO
HomeAuthorLekha badlani

Lekha Badlani

Research Analyst

Money Control

Max Healthcare: A healthy but pricey stock

BUSINESS

Max Healthcare: A healthy but pricey stock

The healthcare company’s medium-term revenue growth visibility appears healthy

Medanta: Charting a growth path

BUSINESS

Medanta: Charting a growth path

Medanta has strong capabilities to leverage its brand image and win the underserved and growing markets.

KIMS: Why are we turning optimistic on this healthcare stock?

BUSINESS

KIMS: Why are we turning optimistic on this healthcare stock?

KIMS is well-positioned to seize the growing demand for healthcare facilities in the country. Timely execution and ramp-up of new projects will be crucial

Rainbow Children’s Medicare: New hospitals act as the growth tonic

BUSINESS

Rainbow Children’s Medicare: New hospitals act as the growth tonic

The company is best placed to benefit from the synergies between paediatric and OB-GYN segments

Fertiliser stocks: Why a normal monsoon may not bring all the cheer

BUSINESS

Fertiliser stocks: Why a normal monsoon may not bring all the cheer

Much will depend on subsidy rates as raw material prices are rising

Krsnaa Diagnostics: Expanding addressable market with a B2C foray

BUSINESS

Krsnaa Diagnostics: Expanding addressable market with a B2C foray

With the ramp-up of new projects, the current revenue growth trajectory should continue into FY25-26

Apollo Hospitals: Strong Q1 FY25, growth momentum to continue

BUSINESS

Apollo Hospitals: Strong Q1 FY25, growth momentum to continue

AHEL expansion plans are on track to add about 1,890 beds by FY26

NMDC Q1 FY25: Strong profit growth unlikely to stage a repeat show

BUSINESS

NMDC Q1 FY25: Strong profit growth unlikely to stage a repeat show

The company has reduced prices for iron ore lumps and fines by 10 percent each

Hindalco reports in-line Q1 numbers, outlook remains moderate

BUSINESS

Hindalco reports in-line Q1 numbers, outlook remains moderate

Top-line growth was muted; EBITDA improved marginally

PI Industries: Strong Q1FY25, but growth momentum slows

BUSINESS

PI Industries: Strong Q1FY25, but growth momentum slows

The company has reiterated about 15% top-line growth and 25-26% EBITDA margin in FY25.

Hindalco: Tepid performance from Novelis in Q1 FY25

BUSINESS

Hindalco: Tepid performance from Novelis in Q1 FY25

Demand environment across end-use segments remains a mixed bag

Vijaya Diagnostic Centre: Why this test result excites us

BUSINESS

Vijaya Diagnostic Centre: Why this test result excites us

Focused on replicating its home market success in the eastern and western regions of the country.

Dhanuka Agritech Q1 FY25: Another resilient quarter; outlook remains positive

BUSINESS

Dhanuka Agritech Q1 FY25: Another resilient quarter; outlook remains positive

Supported by a good monsoon trend, the management expects to achieve a lower double-digit revenue growth in Q2FY25.

Tata Steel: Uninspiring Q1 FY25 prompts revision of risk-reward opportunity

BUSINESS

Tata Steel: Uninspiring Q1 FY25 prompts revision of risk-reward opportunity

As global steel demand remains muted, excess cheap Chinese imports remain a concern.

Coal India: Decent show in Q1 FY25; levers in place for long-term gain

BUSINESS

Coal India: Decent show in Q1 FY25; levers in place for long-term gain

India’s power demand is expected to see solid growth in the coming years

IPO: Should investors bet on the largest pharma contract manufacturer of India?

BUSINESS

IPO: Should investors bet on the largest pharma contract manufacturer of India?

Successful execution of CDMO expansion and profitability of the API business need to be watched

Jindal Steel and Power Q1: Resilient show in a tough market environment

BUSINESS

Jindal Steel and Power Q1: Resilient show in a tough market environment

JSPL’s cost-saving and capacity expansion projects, aided by high-margin products, should drive better earnings in FY25-26.

The Budget policy measures for agriculture are too late, too little!

BUSINESS

The Budget policy measures for agriculture are too late, too little!

The much-needed initiatives that could boost farm income found no mention in the Union Budget

JSW Steel: Q1 FY25 weaker than expected; levers in place for better FY25

BUSINESS

JSW Steel: Q1 FY25 weaker than expected; levers in place for better FY25

Company’s focus on value-added special steel products should support realisation.

Coal India revises e-auction norms: Is there more upside to the stock now?

BUSINESS

Coal India revises e-auction norms: Is there more upside to the stock now?

Offering more volumes through the e-auction route should help cater to the unserved domestic demand

What can the Union Budget do to address the woes of Indian agriculture?

BUSINESS

What can the Union Budget do to address the woes of Indian agriculture?

Budget 2024-25: It is time for policymakers to realise that incentives will never be enough and will only increase the fiscal burden year on year. The sector will need viable solutions for a sustained growth

Krsnaa Diagnostics: A stock to ride the theme of inclusive healthcare

BUSINESS

Krsnaa Diagnostics: A stock to ride the theme of inclusive healthcare

With the ramp-up of new projects, the current revenue growth trajectory should continue into FY25-26

Bansal Wire Industries IPO: Should you make it part of your portfolio?

BUSINESS

Bansal Wire Industries IPO: Should you make it part of your portfolio?

Successful execution of its product expansion to new segments will be key to watch

PI Industries adds another feather in its cap with this new acquisition

BUSINESS

PI Industries adds another feather in its cap with this new acquisition

The acquisition of UK-based Plant Health Care will be value-accretive for PI as it will make the company an integrated agri-solutions provider

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347